SCHEMBL3977129

SCHEMBL3977129

CC(=O)N(Cc1ccccc1)c1cccc(-c2ccoc2C(=O)NN)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 2/20 0.45
LTB4R2 Q9NPC1 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HTT P42858 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPK14 Q16539 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 2/20 0.39
JAK2 O60674 1/20 0.39
PAX8 Q06710 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HDAC6 Q9UBN7 1/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3976444 0.83 TSPO (0.46) TSPOLTB4R2L3MBTL1PTGDR2CRHBP
SCHEMBL2669092 0.80 GCGR (0.40) TSPOLTB4R2NPC1MEN1KMT2A
SCHEMBL3979353 0.80 KISS1R (0.36) TSPOLTB4R2L3MBTL1PTGDR2ALDH1A1
SCHEMBL4285451 0.76 MAPT (0.43) L3MBTL1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL3975306 0.73 SMPD1 (0.49) ALDH1A1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL3973274 0.73 NR1H4 (0.51) ALDH1A1HTTKDM4EHDAC6LMNA
SCHEMBL3978197 0.72 ALDH1A1 (0.48) ALDH1A1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL3978096 0.72 MEN1 (0.50) ALDH1A1HTTKDM4ERAB9ANPC1
SCHEMBL24166877 0.71 TSPO (0.66) TSPOLTB4R2L3MBTL1CRHBPCRHR2
SCHEMBL3982143 0.71 KCNK3 (0.52) ALDH1A1KDM4ERAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 TSPO 2878/4885LTB4R2 437/4885L3MBTL1 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.